Benita von Glahn

Company: Boehringer Ingelheim Pharma GmbH & Co. KG Regulatory Affairs Biosimilars

Pharmacist by training with PhD in pharmaceutical chemistry from University of Heidelberg, Germany. Started in pharmaceutical industry in 1998, in German Drug Regulatory Affairs at Mundipharma, Limburg (Lahn), Germany. In 2002 took a position in Regulatory Affairs Immunology at Abbott. From July 2007 lead the International Regulatory Affairs Team Immunology and was appointed in Jan 2011 as TA Head for Humira within Global Regulatory Strategy. Joined Boehringer Ingelheim in February 2013 as Head of Development Regulatory Affairs, Biosimilars. Master’s degree of Drug Regulatory Affairs from University of Bonn in 2008 and a Special Pharmacist degree for Drug Information in 2007.